BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Recruiting now

Conditions studied: Atrial Fibrillation New Onset, Acute Myocardial Infarction

In brief

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

Key facts

Study ID
NCT04528511
Run by
Shanghai 10th People's Hospital
People needed
774
Starts
2020-10-01
Expected to finish
2028-06-30
Last updated by the study team
2026-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.